Published in Dtsch Arztebl Int on December 11, 2009
Knowledge about umbilical cord blood banking among Greek citizens. Blood Transfus (2013) 0.94
Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv (2010) 0.90
Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth. Cell Transplant (2012) 0.88
Stem cell applications in military medicine. Stem Cell Res Ther (2011) 0.83
The price of hope: is autologous cord blood storage necessary and useful? Dtsch Arztebl Int (2009) 0.75
Re: Stem cells derived from cord blood in transplantation and regenerative medicine. Further phenomena. Dtsch Arztebl Int (2010) 0.75
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell (2008) 10.68
Clinical transplantation of a tissue-engineered airway. Lancet (2008) 10.04
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet (2007) 6.93
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med (1989) 5.81
A fresh look at iPS cells. Cell (2009) 5.73
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood (2009) 3.62
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke (2004) 2.40
Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant (2008) 2.23
NHS maternity units should not encourage commercial banking of umbilical cord blood. BMJ (2006) 1.99
First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics (2007) 1.53
Cord blood banking for potential future transplantation. Pediatrics (2007) 1.47
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J (2008) 1.45
Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol (2008) 1.34
Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res (2003) 1.21
Stem cells used for cardiovascular tissue engineering. Eur J Cardiothorac Surg (2008) 1.19
Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? Haematologica (2009) 1.18
Placental blood transplantation and autologous banking--caveat emptor. J Pediatr Hematol Oncol (1997) 1.14
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells (2007) 1.14
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant (2007) 1.13
Cord blood banking for potential future transplantation: subject review. American Academy of Pediatrics. Work Group on Cord Blood Banking. Pediatrics (1999) 1.08
Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev (2008) 1.08
Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol (2006) 1.08
Future of cord blood for non-oncology uses. Bone Marrow Transplant (2009) 1.08
Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can (2005) 1.07
Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One (2008) 1.06
Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation (2006) 1.02
Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification. Dtsch Arztebl Int (2008) 1.02
Autologous hematopoietic stem cell transplantation for type 1 diabetes. Ann N Y Acad Sci (2008) 1.01
ACOG committee opinion number 399, February 2008: umbilical cord blood banking. Obstet Gynecol (2008) 0.91
Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev (2008) 0.90
Genomic assessment of pediatric acute leukemia. Cancer J (2005) 0.87
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg (2006) 0.87
In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy (2007) 0.84
Cord blood for tissue regeneration. J Cell Biochem (2009) 0.84
Parkinson's disease mice and human umbilical cord blood. J Med (2002) 0.82
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA (2009) 0.81
Genomic analysis of acute leukemia. Int J Lab Hematol (2009) 0.81
Seventh Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, June 5-6, 2009. Biol Blood Marrow Transplant (2009) 0.80
Cardiac tissue engineering. Eur J Cardiothorac Surg (2008) 0.77
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol (2005) 3.72
Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat Methods (2012) 2.64
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood (2009) 2.57
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. J Clin Oncol (2013) 1.97
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood (2009) 1.94
A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia. Blood (2010) 1.91
Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell (2007) 1.87
Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem (2008) 1.72
Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood (2004) 1.67
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood (2003) 1.65
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood (2011) 1.64
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine. Blood (2010) 1.62
Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood (2008) 1.56
HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty. Acta Ophthalmol Scand (2004) 1.56
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol (2003) 1.52
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol (2010) 1.47
Portal application of human unrestricted somatic stem cells to support hepatic regeneration after portal embolization and tumor surgery. ASAIO J (2012) 1.42
Oxygen tension modifies the 'stemness' of human cord blood-derived stem cells. Cytotherapy (2012) 1.41
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica (2008) 1.41
High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res (2004) 1.36
International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol (2009) 1.35
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. Blood (2011) 1.25
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group. J Clin Oncol (2006) 1.25
Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood (2004) 1.23
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood (2007) 1.23
MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev (2010) 1.21
Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev (2010) 1.14
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica (2011) 1.14
Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells? Stem Cells Dev (2012) 1.07
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer (2003) 1.06
Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Hematol (2010) 1.06
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia. Haematologica (2010) 1.02
No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia. J Clin Oncol (2010) 1.00
Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood (2011) 1.00
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. Blood (2003) 0.97
The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica (2011) 0.97
DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev (2010) 0.97
Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood (2006) 0.97
Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells. J Pharmacol Exp Ther (2004) 0.96
Nucleofection, an efficient nonviral method to transfer genes into human hematopoietic stem and progenitor cells. Stem Cells Dev (2006) 0.96
Comparison of ectopic bone formation of embryonic stem cells and cord blood stem cells in vivo. Tissue Eng Part A (2010) 0.95
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol (2010) 0.94
The HOX Code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res (2010) 0.94
Generation and differentiation of microtissues from multipotent precursor cells for use in tissue engineering. Nat Protoc (2011) 0.93
In vitro differentiation of unrestricted somatic stem cells into functional hepatic-like cells displaying a hepatocyte-like glucose metabolism. J Cell Physiol (2010) 0.92
Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med (2009) 0.92
Osteogenic differentiation influences stem cell migration out of scaffold-free microspheres. Tissue Eng Part A (2010) 0.90
Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev (2008) 0.90
Transplantation of human umbilical cord blood-derived adherent progenitors into the developing rodent brain. J Neuropathol Exp Neurol (2005) 0.90
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring. Cytometry B Clin Cytom (2005) 0.90
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann Hematol (2011) 0.89
Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol (2010) 0.87
Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. Br J Haematol (2009) 0.86
Biocompatibility of osteogenic predifferentiated human cord blood stem cells with biomaterials and the influence of the biomaterial on the process of differentiation. J Biomater Appl (2010) 0.85
Cord blood for tissue regeneration. J Cell Biochem (2009) 0.84
HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol (2003) 0.84
Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependent. J Cell Mol Med (2008) 0.82
Improvement of the cell-loading efficiency of biomaterials by inoculation with stem cell-based microspheres, in osteogenesis. J Biomater Appl (2010) 0.82
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Leuk Res (2010) 0.82
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2. Stem Cells Dev (2014) 0.82
Impact of DAG stimulation on mineral synthesis, mineral structure and osteogenic differentiation of human cord blood stem cells. Stem Cell Res (2011) 0.82
Neonatal mesenchymal-like cells adapt to surrounding cells. Stem Cell Res (2013) 0.81
Comparing the gene expression profile of stromal cells from human cord blood and bone marrow: lack of the typical "bone" signature in cord blood cells. Stem Cells Int (2013) 0.81
Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem (2008) 0.81
Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia. Leuk Res (2012) 0.81
Unrestricted somatic stem cells: interaction with CD34+ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential. Cytotherapy (2010) 0.81
Population pharmacokinetics of liposomal daunorubicin in children. Br J Clin Pharmacol (2003) 0.81
In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets. Blood (2005) 0.81
In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica (2006) 0.81
Increased Haematopoietic Supportive Function of USSC from Umbilical Cord Blood Compared to CB MSC and Possible Role of DLK-1. Stem Cells Int (2013) 0.80
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia. Clin Cancer Res (2008) 0.80
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Ann Hematol (2015) 0.80
Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML. Blood (2007) 0.80
Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells. Immunology (2009) 0.79
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. Br J Haematol (2014) 0.79
The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays. Stem Cells Int (2013) 0.79
Survival, integration, and differentiation of unrestricted somatic stem cells in the heart. Cell Transplant (2013) 0.79
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. PLoS One (2013) 0.78
The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia. Int J Oncol (2004) 0.78
[Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease]. Med Klin (Munich) (2006) 0.77
Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia? Blood (2006) 0.77
Efficiency and safety of chemotherapy plans for children: CATIPO--a nationwide approach. Artif Intell Med (2002) 0.77
[Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells]. Med Klin (Munich) (2005) 0.76
A novel culture device for the evaluation of three-dimensional extracellular matrix materials. J Tissue Eng Regen Med (2012) 0.76
Transplanted human cord blood-derived unrestricted somatic stem cells preserve high-energy reserves at the site of acute myocardial infarction. Cytotherapy (2011) 0.76
Long term survival in children with acute leukaemia and complications requiring mechanical ventilation. Arch Dis Child (2011) 0.76
Proteomic Profiling of Ex Vivo Expanded CD34-Positive Haematopoetic Cells Derived from Umbilical Cord Blood. Stem Cells Int (2013) 0.76
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer (2004) 0.75
Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma. Expert Rev Hematol (2009) 0.75
Getting the numbers straight in pediatric MDS: distribution of subtypes after exclusion of down syndrome. Pediatr Blood Cancer (2008) 0.75